Rubius Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2019 to Q4 2022

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Rubius Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2019 to Q4 2022.
  • Rubius Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2022 was 452 %, a 51.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2022 452 -488 -51.9% Dec 31, 2022
Q3 2022 522 -432 -45.3% Sep 30, 2022
Q2 2022 656 -256 -28% Jun 30, 2022
Q1 2022 823 -8.07 -0.97% Mar 31, 2022
Q4 2021 940 +164 +21.1% Dec 31, 2021
Q3 2021 954 +126 +15.2% Sep 30, 2021
Q2 2021 912 +14.9 +1.67% Jun 30, 2021
Q1 2021 831 -232 -21.8% Mar 31, 2021
Q4 2020 776 -479 -38.2% Dec 31, 2020
Q3 2020 828 -740 -47.2% Sep 30, 2020
Q2 2020 897 -1.13K -55.7% Jun 30, 2020
Q1 2020 1.06K -886 -45.5% Mar 31, 2020
Q4 2019 1.26K Dec 31, 2019
Q3 2019 1.57K Sep 30, 2019
Q2 2019 2.03K Jun 30, 2019
Q1 2019 1.95K Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.